Yajing Chen, Phd Email and Phone Number
Yajing Chen, Phd work email
- Valid
- Valid
Yajing Chen, Phd personal email
- Valid
Senior finance leader with 20 years of global experience in the life sciences at Zai Lab, AstraZeneca, and Quest Diagnostics. Business partner recognized for deep business acumen spanning R&D, sales, marketing, market access and operation. Skilled in establishing new processes, developing teams, and delivering challenging goals. PhD in Microbiology from New York University and MBA from Columbia Business School. Fluent in English and Chinese. Specialties: Finance, corporate finance, CFO, life sciences, pharmaceutical, biotechnology, biotech, biopharmaceutical, international, global, business partner, commercial, R&D, research, development, line management, supervision, financial analysis, analytical skills, decision support, decision making, problem solving, negotiation, strategy, strategic planning, process improvement, change management, leadership, executive leadership, management, team building, talent development, forecasting, budgeting, valuation, business development, alliance management, corporate development, due diligence, critical thinking, business acumen, financial modeling, financial planning, financial reporting, FP&A, GAAP, IFRS, project management, P&L, margin expansion, profit, growth, cost optimization, KPIs, board presentations, cross-functional collaboration, relationship building
Zai Lab
View-
Chief Financial OfficerZai Lab Jul 2023 - PresentZhangjiang Hi-Tech Park, Pudong, Shanghai, CnZai Lab (ZLAB) is NASDAQ and HKEX dual listed commercial stage biopharmaceutical company with more than $200 million in revenue. We are focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world.
-
Deputy Chief Financial OfficerZai Lab Sep 2021 - Jul 2023Zhangjiang Hi-Tech Park, Pudong, Shanghai, Cn
-
Cfo, Us Oncology BusinessAstrazeneca 2019 - 2021Cambridge, Cambridgeshire, GbLed a team of 20 finance professionals supporting a $4.3 billion business. Scope included commercial and market access strategy, decision support, FP&A, gross to net (GTN) accounting, and US alliance management. Grew profit 43% and revenue 34% revenue by shaping resource allocation for launches of new product and new indications. -
Finance Controller, Global Oncology Business UnitAstrazeneca 2016 - 2019Cambridge, Cambridgeshire, GbLed a global team of 8 supporting a $6B business. Scope included commercial strategy, pipeline prioritization, decision support for business development, FP&A, as well as finance business partner support to a $2 billion region that included Japan and China. Achieved 29% global revenue CAGR by facilitating establishment of new global oncology business unit.
-
Senior Finance Director, Global Oncology Therapeutic AreaAstrazeneca 2016 - 2016Cambridge, Cambridgeshire, GbLed development of 10-year strategic plan for oncology therapy area which guided business development, pipeline prioritization, and commercial strategy, enabling AZ to grow oncology revenue from $3 to $10 billion in 5 years.
-
R&D Global Project Finance DirectorAstrazeneca 2013 - 2016Cambridge, Cambridgeshire, GbGuided strategy and provided financial decision support for late stage development of Imfinzi®. Enhanced R&D productivity and transformed clinical study design process by championing clinical study cost transparency. Earned CFO award for impact.
-
Commercial Finance Director, Specialty Care Business UnitAstrazeneca 2012 - 2013Cambridge, Cambridgeshire, GbLed a team of 4 supporting $1 billion US specialty business. Scope included decision support, FP&A, and GTN accounting for Synagis®, FluMist®, Caprelsa®, and Faslodex®. Maintained Synagis revenue following change to treatment guidelines by influencing pricing and contracting strategies, as well as guiding resource allocation.
-
Finance Director, Biologics R&DAstrazeneca 2010 - 2012Cambridge, Cambridgeshire, GbLed a global team of 10 finance professionals managing a $600 million R&D budget. Expanded biologics portfolio by providing financial models used in negotiation of Amgen collaboration for co-development of 5 monoclonal antibodies (mABs) for treatment of inflammatory diseases.
-
Associate Finance Director, Biologics R&DAstrazeneca 2008 - 2010Cambridge, Cambridgeshire, GbFollowing MedImmune acquisition, drove integration of biologics R&D capabilities and harmonization of R&D reporting.
-
Senior Finance Manager, Medimmune R&DAstrazeneca 2006 - 2008Cambridge, Cambridgeshire, GbEnhanced R&D long range planning, portfolio prioritization, and R&D resource allocation decisions by implementing use of new-to-MedImmune valuation models, as well as providing total project cost visibility. Accelerated monthly close process 60% and increased forecast accuracy to 95% by redesigning financial processes.
-
Senior Finance Manager, Hospital BusinessQuest Diagnostics 2003 - 2006Secaucus, Nj, UsResponsible for finance and accounting in $800 million business within this $6 billion clinical laboratory company. Supervised 2 financial professionals. Established new reporting tool that provided first-ever insight into performance by client, payer, product, and market segment. Earned CEO award for impact. -
Manager, Corporate Financial Planning And Analysis (Fp&A)Quest Diagnostics 2001 - 2003Secaucus, Nj, UsProvided financial oversight and decision support for strategic growth initiatives, capital investments, and corporate operational excellence programs.
-
Senior Financial AnalystUs Airways 2000 - 2001UsGenerated $2 million in incremental revenue by leading project to improve the change fee revenue audit process.
Yajing Chen, Phd Skills
Yajing Chen, Phd Education Details
-
Columbia Business SchoolMaster Of Business Administration - Mba -
New York UniversityMicrobiology
-
Wuhan UniversityBiology
Frequently Asked Questions about Yajing Chen, Phd
What company does Yajing Chen, Phd work for?
Yajing Chen, Phd works for Zai Lab
What is Yajing Chen, Phd's role at the current company?
Yajing Chen, Phd's current role is Chief Financial Officer at Zai Lab | Strategic Finance Business Partner | Biopharmaceutical Industry.
What is Yajing Chen, Phd's email address?
Yajing Chen, Phd's email address is ya****@****hoo.com
What schools did Yajing Chen, Phd attend?
Yajing Chen, Phd attended Columbia Business School, New York University, Wuhan University.
What skills is Yajing Chen, Phd known for?
Yajing Chen, Phd has skills like Biotechnology, Forecasting, Pharmaceutical Industry, Biopharmaceuticals, Mergers And Acquisitions, Analysis, Cross Functional Team Leadership, Finance, Leadership, Clinical Development, Oncology, Life Sciences.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial